GilesWilliamRobinsonMD

Summary

• Giles W. Robinson, M.D., is a pediatric neuro-oncologist currently practicing at St. Jude Children’s Research Hospital in Memphis, TN. His primary career objective is to improve the survival and reduce the treatment-related morbidity of children with central nervous system tumors.
  
  He believes that the best way to achieve this goal is to fundamentally understand these complex and challenging diseases. Thus, he seeks to explore and comprehend the genomic and molecular basis of central nervous system tumors and use this knowledge to better inform therapy.
  
  While he treats all pediatric brain tumors, a focus of his research efforts has been on medulloblastoma. In particular, he has studied and published on the genomics of this tumor. As co-PI of a multi-institutional protocol “A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma (NCT01878617)” he has developed, launched, and operated the first clinical trial to tailor therapy according to the molecular makeup of the tumor.
  
  Recently, he launched a multi-armed clinical trial for recurrent or relapsed CNS tumors that targets pathways that are commonly aberrated in these tumors (SJDAWN; NCT03434262). These endeavors would not have been possible without extensive collaborations and he looks forward to new and continued projects as there is much more knowledge to be gained and applied. As such, he is proud of his ability to work with and learn from others as a path is forged toward better therapy for children with cancer.